Superiority of platelet integrin GPIIb-IIIa receptor antagonist over aspirin in preventing cyclic flow reductions in the guinea pig middle cerebral artery

Author： Kawano K.-i.   Ikeda Y.   Kondo K.   Umemura K.  

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.374, Iss.3, 1999-06, pp. : 377-385

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting the Platelet Integrin GPIIb/IIIa

By  

Current Pharmaceutical Design, Vol. 16, Iss. 37, 2010-12 ,pp. : 4119-4133

Bentham Science Publishers

Access to resources Recommend Favorite

Evaluation of a GPIIb/IIIa antagonist YM337 in a primate model of middle cerebral artery thrombosis

By Kaku S.   Umemura K.   Mizuno A.   Yano S.   Suzuki K.-i.   Kawasaki T.   Nakashima M.  

European Journal of Pharmacology, Vol. 345, Iss. 2, 1998-03 ,pp. : 185-192

Elsevier

Access to resources Recommend Favorite

Thromboxane A 2 synthase inhibitor enhanced antithrombotic efficacy of GPIIb-IIIa receptor antagonist without increasing bleeding

By Kawano K.-i.   Hokamura K.   Kondo K.   Ikeda Y.   Suzuki Y.   Umemura K.  

European Journal of Pharmacology, Vol. 417, Iss. 3, 2001-04 ,pp. : 217-222

Elsevier

Access to resources Recommend Favorite

UR-3216: A New Generation Oral Platelet GPIIb / IIIa Antagonist

By  

Current Pharmaceutical Design, Vol. 10, Iss. 14, 2004-05 ,pp. : 1597-1601

Bentham Science Publishers

Access to resources Recommend Favorite

Update on GPIIb/IIIa antagonists

By Hanson Julien   de Leval Xavier   Kolh Philippe   Supuran Claudiu   Pirotte Bernard   Dogné Jean-Michel  

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 8, 2003-08 ,pp. : 1173-1188

Informa Healthcare

Access to resources Recommend Favorite